Literature DB >> 26384463

Loss-of-function mutations of STXBP1 in patients with epileptic encephalopathy.

Toshiyuki Yamamoto1, Keiko Shimojima2, Tamami Yano3, Yuki Ueda4, Rumiko Takayama4, Hiroko Ikeda4, Katsumi Imai4.   

Abstract

Epileptic encephalopathy, which commences during early infancy, is a severe epileptic syndrome that manifests as age-dependent seizures and severe developmental delay. The syntaxin-binding protein 1 gene (STXBP1) is one of the genes responsible for epileptic encephalopathy. We conducted a cohort study to analyze STXBP1 in 42 patients with epileptic encephalopathy. We identified four novel mutations: two splicing mutations, a frameshift mutation, and a nonsense mutation. All of these mutations were predicted to cause loss-of-function. This result suggests loss-of-function is a common mechanism underlying STXBP1-related epileptic encephalopathy. The four patients showed epileptic features consistent with STXBP1-related epileptic encephalopathy, but showed variable radiological findings, including brain volume loss and myelination delay.
Copyright © 2015 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Loss-of-function; Ohtahara syndrome; STXBP1-related epileptic encephalopathy; West syndrome

Mesh:

Substances:

Year:  2015        PMID: 26384463     DOI: 10.1016/j.braindev.2015.09.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

1.  Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish.

Authors:  Brian P Grone; Maria Marchese; Kyla R Hamling; Maneesh G Kumar; Christopher S Krasniak; Federico Sicca; Filippo M Santorelli; Manisha Patel; Scott C Baraban
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

2.  Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy.

Authors:  Jovana Kovacevic; Gregoire Maroteaux; Desiree Schut; Maarten Loos; Mohit Dubey; Julika Pitsch; Esther Remmelink; Bastijn Koopmans; James Crowley; L Niels Cornelisse; Patrick F Sullivan; Susanne Schoch; Ruud F Toonen; Oliver Stiedl; Matthijs Verhage
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

3.  Clemizole and trazodone are effective antiseizure treatments in a zebrafish model of STXBP1 disorder.

Authors:  Maia Moog; Scott C Baraban
Journal:  Epilepsia Open       Date:  2022-05-17

4.  STXBP1-associated neurodevelopmental disorder: a comparative study of behavioural characteristics.

Authors:  Sinéad O'Brien; Elise Ng-Cordell; Duncan E Astle; Gaia Scerif; Kate Baker
Journal:  J Neurodev Disord       Date:  2019-08-06       Impact factor: 4.025

Review 5.  Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review.

Authors:  Shunli Liu; Liyuan Wang; Xiao Tang Cai; Hui Zhou; Dan Yu; Zhiling Wang
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.